In these video interviews, Dr Eric Jonasch from MD Anderson Cancer Center in Texas and Dr Monty Pal from the City of Hope Hospital in California talk about immune-related adverse events in people with advanced kidney cancer taking combination therapies and immunotherapy:

Managing Adverse Events Among RCC Patients Receiving Combination Treatment With Targeted Therapy and Immunotherapy

Immune-Related Adverse Events in Advanced Kidney Cancer